Skip to main content

Advertisement

Log in

Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformation

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

The localized activation of coagulation in vascular malformations can lead to a consumptive coagulopathy characterized by elevated D-dimers and a consumption of fibrinogen and platelets, eventually giving rise to a bleeding tendency. By reducing coagulation activation, anticoagulant treatment with heparin is able to limit this haemostatic dysregulation and the associated bleeding diathesis. Here, we present a case of a consumptive coagulopathy due to a large venous malformation with a sustained correction of the fibrinogen depletion and associated bleeding tendency both with subcutaneous enoxaparin and with the oral factor Xa inhibitor rivaroxaban.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Hermans C, Dessomme B, Lambert C, Deneys V (2006) Venous malformations and coagulopathy. Ann Chir Plast Esthet 51(4–5):388–393. doi:10.1016/j.anplas.2006.07.009

    Article  CAS  PubMed  Google Scholar 

  2. Martin LK, Russell S, Wargon O (2009) Chronic localized intravascular coagulation complicating multifocal venous malformations. Aus J Dermatol 50(4):276–280. doi:10.1111/j.1440-0960.2009.00558.x

    Article  Google Scholar 

  3. Dompmartin A, Acher A, Thibon P, Tourbach S, Hermans C, Deneys V, Pocock B, Lequerrec A, Labbe D, Barrellier MT, Vanwijck R, Vikkula M, Boon LM (2008) Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 144(7):873–877. doi:10.1001/archderm.144.7.873

    Article  PubMed  Google Scholar 

  4. Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L (2002) Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach–Merritt syndrome. Clin Lab Haematol 24(4):243–251

    Article  PubMed  Google Scholar 

  5. Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L (2008) Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol 144(7):861–867. doi:10.1001/archderm.144.7.861

    Article  PubMed  Google Scholar 

  6. Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D (1997) Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol 36(2 Pt 1):219–225

    Article  CAS  PubMed  Google Scholar 

  7. Scola M, Brophy M, Fiore L (2001) Localized consumptive coagulopathy. Circulation 104(1):120–121

    Article  CAS  PubMed  Google Scholar 

  8. Garzon MC, Huang JT, Enjolras O, Frieden IJ (2007) Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol 56(4):541–564. doi:10.1016/j.jaad.2006.05.066

    Article  PubMed  Google Scholar 

  9. Bick RL (1981) Hereditary hemorrhagic telangiectasia and disseminated intravascular coagulation: a new clinical syndrome. Ann N Y Acad Sci 370:851–854

    Article  CAS  PubMed  Google Scholar 

  10. Verstraete M, Amery A, Vermylen C, Robyn G (1963) Heparin treatment of bleeding. Lancet 1(7278):446

    Article  CAS  PubMed  Google Scholar 

  11. Feinstein DI (1982) Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 60(2):284–287

    CAS  PubMed  Google Scholar 

  12. Jelenska MM, Szmidt J, Bojakowski K, Grzela T, Palester-Chlebowczyk M (2004) Compensated activation of coagulation in patients with abdominal aortic aneurysm: effects of heparin treatment prior to elective surgery. Thromb Haemost 92(5):997–1002. doi:10.1267/THRO04050997

    CAS  PubMed  Google Scholar 

  13. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New Engl J Med 365(10):883–891. doi:10.1056/NEJMoa1009638

    Article  CAS  PubMed  Google Scholar 

  14. EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S (2010) Oral rivaroxaban for symptomatic venous thromboembolism. New Engl J Med 363(26):2499–2510. doi:10.1056/NEJMoa1007903

    Article  CAS  PubMed  Google Scholar 

  15. EINSTEIN-PE Investigators, Buller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. New Engl J Med 366(14):1287–1297. doi:10.1056/NEJMoa1113572

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christophe Vandenbriele.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vandenbriele, C., Vanassche, T., Peetermans, M. et al. Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformation. J Thromb Thrombolysis 38, 121–123 (2014). https://doi.org/10.1007/s11239-013-1024-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-013-1024-7

Keywords

Navigation